US newspaper The Washington Post has predicted worldwide success for Russia’s coronavirus vaccine
The authors of the article in WP note that previously many people regarded the Russian vaccine with great doubt, but after the publication of the results of the third phase of the clinical trial in the authoritative scientific journal The Lancet have changed their opinion.
“Now Sputnik V – named after the world’s first satellite, thanks to which the Soviet Union initially beat America in the space race – is starting to look like it could become a global success story”, – the paper believes.
WP also stressed that the Russian vaccine Sputnik V is much cheaper than Western analogues and does not require storage at extremely low temperatures.
The Sputnik V coronavirus vaccine has been developed by the Gamaleya Research and Development Centre. The drug is based on a well-studied adenovirus platform, which ensures high efficacy and safety.